161 related articles for article (PubMed ID: 30803276)
1. Efficacy of Sunitinib, Sunitinib-Hesperetin, and Sunitinib-Doxycycline Combinations on Experimentally-Induced Corneal Neovascularization.
Ekim Y; Kara S; Gencer B; Karaca T
Curr Eye Res; 2019 Jun; 44(6):590-598. PubMed ID: 30803276
[No Abstract] [Full Text] [Related]
2. Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis.
Dan L; Shi-long Y; Miao-li L; Yong-ping L; Hong-jie M; Ying Z; Xiang-gui W
Curr Eye Res; 2008 Aug; 33(8):653-60. PubMed ID: 18696340
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.
Pérez-Santonja JJ; Campos-Mollo E; Lledó-Riquelme M; Javaloy J; Alió JL
Am J Ophthalmol; 2010 Oct; 150(4):519-528.e1. PubMed ID: 20591397
[TBL] [Abstract][Full Text] [Related]
6. Effect of metronidazole ophthalmic solution on corneal neovascularization in a rat model.
Claros-Chacaltana FDY; Aldrovani M; Kobashigawa KK; Padua IRM; Valdetaro GP; de Barros Sobrinho AAF; Abreu TGM; Laus JL
Int Ophthalmol; 2019 May; 39(5):1123-1135. PubMed ID: 29700650
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
[TBL] [Abstract][Full Text] [Related]
8. The effects of topical everolimus and sunitinib on corneal neovascularization.
Çakmak H; Ergin K; Bozkurt G; Kocatürk T; Evliçoğlu GE
Cutan Ocul Toxicol; 2016; 35(2):97-103. PubMed ID: 25864572
[TBL] [Abstract][Full Text] [Related]
9. Effects of sunitinib and bevacizumab on VEGF and miRNA levels on corneal neovascularization.
Cakmak H; Gokmen E; Bozkurt G; Kocaturk T; Ergin K
Cutan Ocul Toxicol; 2018 Jun; 37(2):191-195. PubMed ID: 28874077
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
Aydin E; Kivilcim M; Peyman GA; Esfahani MR; Kazi AA; Sanders DR
Cornea; 2008 May; 27(4):446-53. PubMed ID: 18434849
[TBL] [Abstract][Full Text] [Related]
11. Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.
Riazi-Esfahani M; Peyman GA; Aydin E; Kazi AA; Kivilcim M; Sanders DR
Cornea; 2006 Aug; 25(7):801-5. PubMed ID: 17068457
[TBL] [Abstract][Full Text] [Related]
12. The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization.
Peyman GA; Kazi AA; Riazi-Esfahani M; Aydin E; Kivilcim M; Sanders DR
Cornea; 2006 Jun; 25(5):582-5. PubMed ID: 16783147
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of TLR4 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model.
Friedman M; Azrad-Lebovitz T; Morzaev D; Zahavi A; Marianayagam NJ; Nicholson JD; Brookman M; Michowiz S; Hochhauser E; Goldenberg-Cohen N
Curr Eye Res; 2019 May; 44(5):505-513. PubMed ID: 30595046
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.
Wu Y; Xue C; Lu Y; Huang Z
Indian J Ophthalmol; 2017 Nov; 65(11):1127-1132. PubMed ID: 29133637
[TBL] [Abstract][Full Text] [Related]
15. Salubrinal Ameliorates Inflammation and Neovascularization via the Caspase 3/Enos Signaling in an Alkaline-Induced Rat Corneal Neovascularization Model.
Ozge G; Karaca U; Savran M; Usta G; Gulle K; Sevimli M; Cankara FN; Asci H
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837524
[No Abstract] [Full Text] [Related]
16. Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model.
Sella R; Gal-Or O; Livny E; Dachbash M; Nisgav Y; Weinberger D; Livnat T; Bahar I
Exp Eye Res; 2016 May; 146():224-232. PubMed ID: 27020759
[TBL] [Abstract][Full Text] [Related]
17. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
[TBL] [Abstract][Full Text] [Related]
18. The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells.
Cheng R; Li C; Li C; Wei L; Li L; Zhang Y; Yao Y; Gu X; Cai W; Yang Z; Ma J; Yang X; Gao G
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3400-9. PubMed ID: 23611999
[TBL] [Abstract][Full Text] [Related]
19. KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.
Li T; Hu A; Li S; Luo Y; Huang J; Yu H; Ma W; Pan J; Zhong Q; Yang J; Wu J; Tang S
Mol Vis; 2011 Mar; 17():797-803. PubMed ID: 21528000
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
Ko BY; Kim YS; Baek SG; Lee GW; Kim JM; Jean WS; Lee NS; Kang J
Cornea; 2013 May; 32(5):689-95. PubMed ID: 23377751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
